AZN vs CLST · P/E 28, $288.38B cap vs P/E 29, rev $7.2M
AstraZeneca PLC (AZN) versus Catalyst Bancorp Inc (CLST) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Catalyst Bancorp Inc (CLST) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CLST revenue for 2026-06-30 was $7.2M. Net income was $1.1M. CLST currently screens at market cap $64.8M and trailing P/E 29.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CLST currently screens at market cap $64.8M and trailing P/E 29.1.
Not investment advice. Open the AZN and CLST stock pages for the full models.
Not investment advice.